| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/07/2007 | US7252821 Cancerous disease modifying antibodies |
| 08/07/2007 | US7252820 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof |
| 08/07/2007 | US7252819 Methods and compositions for correction of cardiac conduction disturbances |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2292953C High-activity phytase granulate |
| 08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
| 08/07/2007 | CA2183079C Method for preparing a multicombinatorial library of antibody gene expression vectors |
| 08/07/2007 | CA2182888C Nucleotide and amino acid sequences of canine herpesvirus gb, gc and gd and uses therefor |
| 08/07/2007 | CA2115565C Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 08/07/2007 | CA2071863C Recombinant vaccine for porcine pleuropneumonia |
| 08/02/2007 | WO2007086879A2 Method of expressing proteins with disulfide bridges |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007085084A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | WO2007056114A3 Compositions and methods for the detection of trypanosoma cruzi infection |
| 08/02/2007 | WO2007050670A3 Expression construct maintenance |
| 08/02/2007 | WO2007008712A3 Anti-alpha v beta 6 antibodies and uses thereof |
| 08/02/2007 | WO2007005918A3 Production of cellulase |
| 08/02/2007 | WO2006131925A3 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/02/2007 | WO2006099160A3 Bioluminescence resonance energy transfer (bret) systems and methods of use thereof |
| 08/02/2007 | WO2005089505A3 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 08/02/2007 | WO2004058044A3 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 08/02/2007 | WO2003029403A3 Targeting proteins to cells expressing mannose receptors via expression in insect cells |
| 08/02/2007 | WO2002062964A3 Ap1 amine oxidase variants |
| 08/02/2007 | US20070180545 TAT-031 and methods of assessing and treating cancer |
| 08/02/2007 | US20070180544 Methods and compositions for autism spectrum disorders |
| 08/02/2007 | US20070179094 Modulation of MDL-1 activity for treatment of inflammatory disease |
| 08/02/2007 | US20070179090 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 08/02/2007 | US20070179089 Structure of SOCS and uses thereof |
| 08/02/2007 | US20070179086 Polypeptides and antibodies |
| 08/02/2007 | US20070178565 Forms (R)-N-benzyl-3-pyrrolidinol; acts on N-benzyl-3-pyrrolidinone with NADH or NADPH as coenzyme, to form (R)-N-benzyl-3-pyrrolidinol |
| 08/02/2007 | US20070178563 Mosaic infectious bursal disease virus vaccines |
| 08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
| 08/02/2007 | US20070178559 Platelet promoting protein and the usage thereof |
| 08/02/2007 | US20070178558 Cloning, sequencing and expression of a Comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 08/02/2007 | US20070178557 Novel N-acetylglucosaminyltransferase, nucleic acid coding for the same, and uses thereof for diagnosis of cancer or tumor |
| 08/02/2007 | US20070178556 Acidovorax facilis 72W nitrilase mutants having improved nitrilase activity for converting glycolonitrile to glycolic acid; 1.5 to 4-fold increase in activity, while maintaining identical reaction conditions |
| 08/02/2007 | US20070178555 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 08/02/2007 | US20070178554 Orthogonal Aminoacyl Synthetase-tRNA Pairs for Incorporating Unnatural Amino Acids Into Proteins |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178552 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
| 08/02/2007 | US20070178551 Methods for producing modified glycoproteins |
| 08/02/2007 | US20070178540 Goodpasture antigen binding protein |
| 08/02/2007 | US20070178539 Novel Cytokine Receptors and Nucleic Acids Encoding the Same |
| 08/02/2007 | US20070178532 Identification, quantification, and characterization of t cells and t cell antigens |
| 08/02/2007 | US20070178528 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 08/02/2007 | US20070178527 Human platelet-derived growth factor receptors |
| 08/02/2007 | US20070178522 Gold-binding protein and use thereof |
| 08/02/2007 | US20070178515 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| 08/02/2007 | US20070178509 kit for the diagnosis or detection of cancer in a mammal; biomarkers for distinguishing between tumors of differing metastatic potential |
| 08/02/2007 | US20070178496 Thermus Thermophilus Nucleic Acid Polymerases |
| 08/02/2007 | US20070178492 Human tumor necrosis factor receptor polynucleotides |
| 08/02/2007 | US20070178490 Hega endonuclease |
| 08/02/2007 | US20070178483 Novel cell-based assays for G-protein-coupled receptor-mediated activities |
| 08/02/2007 | US20070178472 Methods of identifying adipocyte specific genes, the genes identified, and their uses |
| 08/02/2007 | US20070178467 Gm1 promoter and use thereof |
| 08/02/2007 | US20070178462 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof |
| 08/02/2007 | US20070178122 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same |
| 08/02/2007 | US20070178114 Novel kallikrein gene |
| 08/02/2007 | US20070178113 Superantigen conjugate |
| 08/02/2007 | US20070178112 Immunoglobulins; immunogens |
| 08/02/2007 | US20070178109 glycoprotein 120; fusion proteins; myelin basic protein; autoimmune diseases; genetic vaccines |
| 08/02/2007 | US20070178106 Compositions and methods for enhancing nk cell activity |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178098 Interleukin-6 antagonists |
| 08/02/2007 | US20070178097 Interleukin-10 antibodies |
| 08/02/2007 | US20070178096 producing an antibody by inoculating an animal with a polypeptide; monoclonal antibody specifically binds to a zalpha11 polypeptide; treating blood disorders |
| 08/02/2007 | US20070178095 Anti-myostatin antibodies |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178092 Humanized anti-CD3 specific antibodies |
| 08/02/2007 | US20070178091 Combination Therapy |
| 08/02/2007 | US20070178088 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
| 08/02/2007 | US20070178082 Stabilized single domain antibodies |
| 08/02/2007 | US20070178072 Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
| 08/02/2007 | CA2650072A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | CA2637156A1 Methods for modulating mannose content of recombinant proteins |
| 08/02/2007 | CA2597647A1 Method of expressing proteins with disulfide bridges |
| 08/01/2007 | EP1813672A2 Transgenic non-human animals capable of producing heterologous antibodies |
| 08/01/2007 | EP1813671A1 Soluble protein and utilization of the same |
| 08/01/2007 | EP1813668A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 08/01/2007 | EP1812582A2 Single protein production in living cells facilitated by a messenger rna interferase |
| 08/01/2007 | EP1434857B1 Method for production of recombinant proteins in eukaryote cells |
| 08/01/2007 | EP1316617B1 Methods of synthesizing cell-free protein |
| 08/01/2007 | EP1287134B1 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | CN1329521C Small peptide of II type protein, and preparation method |
| 08/01/2007 | CN1329512C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 08/01/2007 | CN1329410C Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e. g. histidine) function |
| 08/01/2007 | CN1329080C Cachexia remedy |
| 08/01/2007 | CN101010427A Anti-A33 antibody |
| 08/01/2007 | CN101010424A Improved methods of producing heterologous proteases |
| 08/01/2007 | CN101010338A Muteins of fibroblast growth factor 21 |
| 08/01/2007 | CN101008027A Enzyme method for hydrolyzing casein and synchronous preparation of phosphopeptide and non-phosphopeptide |
| 08/01/2007 | CN101008026A Method for preparing silkworm chrysalis polypeptide using complex enzyme for hydrolyzing silkworm chrysalis |
| 08/01/2007 | CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007847A Human horny cell growth factor-2 mutant and its preparation method |
| 07/31/2007 | US7250503 Nucleic acid molecules encoding clot-specific streptokinase fusion proteins possessing altered plasminogen activation characteristics |
| 07/31/2007 | US7250501 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein |
| 07/31/2007 | US7250500 Nematode PAN and ZP receptor-like sequences |
| 07/31/2007 | US7250495 PRO20044 polypeptides |